News ArticleMTAR Technologies Secures Rs.504 Crore Order for Kaiga 5&6 Nuclear Projects, Expands in Aerospace and Clean Energy
Company guides for 80% revenue growth and 24% EBITDA margin in fiscal year; showcases new product developments and manufacturing expansions
MTAR Technologies Limited highlights robust order inflows including a Rs.504 crore order for Kaiga 5&6 civil nuclear projects, strategic capacity enhancements, and growth across aerospace, defence, and clean energy sectors in its October 2026 investor presentation.
MTAR Technologies Limited
Investor Presentation
MTAR Technologies Limited announced a significant Rs.504 crore order inflow for Kaiga 5&6 civil nuclear power projects, underscoring strong order visibility in the sector, alongside new product developments and capacity enhancements in aerospace, defence, and clean energy sectors.
The company supplies critical fuel handling assemblies for nuclear reactors and is positioned to benefit from India's target of 100 GWe civil nuclear capacity by 2047. It received over Rs.130 crore in orders from reactor refurbishments and is bidding for new reactor core assemblies for private sector nuclear projects.
In aerospace and defence, MTAR delivers propulsion systems, structural assemblies for LCA Tejas and AMCA programs, and components for global customers like Thales, GKN, IAI, Rafael, and Elbit. The aerospace segment is preparing for volume ramp-ups after successful product qualifications.
MTAR's clean energy vertical spans fuel cells, hydel, and wind energy, with a strong closing order book of Rs.4075.5 crore as of Q2FY27, reflecting growth driven by energy transition trends and data centre infrastructure demands. First article orders worth Rs.45 crore have been received for sheet metal components for data centres.
Strategic initiatives over the past five years include product expansion in civil nuclear, clean energy, and aerospace sectors, establishment of dedicated aerospace manufacturing facilities with NADCAP accreditation, and diversification into oil & gas and data centre infrastructure solutions.
For fiscal year guidance, the company projects 80% revenue growth with an EBITDA margin target of approximately 24%. MTAR continues to focus on product portfolio expansion, increasing customer wallet share, and global customer base growth.
Highlights
- Received largest single order of Rs.504 crore for Kaiga 5&6 nuclear projects.
- Rs.130 crore orders from reactor refurbishments in fiscal 2027.
- Strong Rs.4075.5 crore closing order book in clean energy as of Q2FY27.
- Expanded aerospace exports to major global customers including Thales and GKN.
- Commissioned dedicated aerospace manufacturing facility and NADCAP approved special processes.
- Guided for 80% revenue growth and EBITDA margin around 24% for the current fiscal year.
Key Data Snapshot
What happened
- MTAR Technologies received its single largest order of Rs.504 crore for Kaiga 5&6 nuclear power projects, reinforcing its strong position in civil nuclear power sector.
- The company maintains robust order inflows including Rs.130 crore for reactor refurbishments and is bidding for new projects under government initiatives.
- MTAR guided for 80% revenue growth and a 24% EBITDA margin for the fiscal year, highlighting expectations of continued financial performance improvement.
Key details
- The company supplies critical components across multiple sectors including fuel handling assemblies for nuclear reactors, propulsion systems for launch vehicles, and assemblies for aerospace platforms like LCA Tejas and AMCA.
- MTAR expanded into clean energy verticals such as fuel cells, hydel, and wind energy, with a closing order book of Rs.4075.5 crore by Q2FY27, driven by global energy transition and data centre infrastructure growth.
- New product developments have been made for civil nuclear, aerospace, clean energy, oil & gas, and data centre infrastructure sectors.
- MTAR commissioned a dedicated aerospace manufacturing facility in January 2025 and established NADCAP-approved special processes covering over 30 processes.
Strategic context
- India aims to achieve 100 GWe civil nuclear capacity by 2047, creating long-term opportunities for MTAR's nuclear sector offerings.
- The aerospace sector is poised for volume ramp-ups as qualified programs move from initial articles to scale production globally.
- Growth in clean energy is underpinned by rising power demand, energy transition, and expanding data centre ecosystems worldwide.
- MTAR’s diversification into oil & gas and data centre verticals presents new market avenues for sheet metal components and assemblies.
Highlights
- Received largest single order of Rs.504 crore for Kaiga 5&6 nuclear projects.
- Rs.130 crore orders from reactor refurbishments in fiscal 2027.
- Strong Rs.4075.5 crore closing order book in clean energy as of Q2FY27.
- Expanded aerospace exports to major global customers including Thales and GKN.
- Commissioned dedicated aerospace manufacturing facility and NADCAP approved special processes.
- Guided for 80% revenue growth and EBITDA margin around 24% for the current fiscal year.
Source Information
More News on Investor Presentation
View allLatest corporate announcements and market updates in Investor Presentation.
V-Guard Industries Posts 38.2% Revenue Growth and 71% Profit Increase in Q2 FY27
V-Guard Industries Limited announced a 38.2% year-on-year increase in consolidated net revenue to ₹1,852.89 crore and a 71% rise in profit after tax to ₹111.67 crore for the quarter ended September 30, 2026 (Q2 FY27).
Read Full Story
CAMS Posts 10% Revenue Growth and 14.4% PAT Rise in Q2 FY27 with Mutual Fund AUM Reaching ₹58.4 Lakh Crore
Computer Age Management Services Limited (CAMS) reported a 10% year-on-year increase in operating revenue to ₹414.47 crore for Q2 FY27, along with a 14.4% rise in profit after tax (PAT) to ₹131.49 crore. The standalone and consolidated financial results for the quarter and half year ended September 30, 2026, highlight strong mutual fund operational growth and significant expansion in non-mutual fund businesses.
Read Full Story
Strides Pharma Posts 17% Revenue Growth to ₹14,297 Crore in Q2 FY27, Ex-US Markets Surpass US Revenues
Strides Pharma Science Limited reported a 17.1% year-on-year revenue growth to ₹14,297 crore for the quarter ended September 30, 2026, with Ex-US markets expanding by 31%, exceeding US revenues for the first time. The company's EBITDA reached ₹2,509 crore, and Operational PAT grew 11.5% to ₹1,358 crore despite challenges from higher raw material and freight costs.
Read Full Story
